Description
Sunitinib Malate Capsules is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults. Sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pNET) with disease progression in adults.
Reviews
There are no reviews yet.